PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40152437,Second line advanced or metastatic non-small cell lung cancer treatment after chemo-immunotherapy: a retrospective study.,2025-Mar-28,Beilei Cai,"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.",N/A
40143547,Oncolytic Viruses as Cancer Therapeutics: From Mechanistic Insights to Clinical Translation.,2025-Mar-25,"Akram Alwithenani, Pranaidej Hengswat, E Antonio Chiocca","Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA., Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: eachiocca@mgb.org.",N/A
